Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Armstrong Pharmaceuticals
Canton, Massachusetts, United Statesarmstrong-pharma.com ↗
- Ownership
- Private
- Employees
- ~31
- Development stage
- Other
01
Overview
Armstrong Pharmaceuticals specialized in the development and manufacture of pharmaceutical products, primarily focusing on inhaled respiratory drugs delivered via Metered Dose Inhalers. Its most notable product was Primatene® MIST, an over-the-counter epinephrine inhaler for temporary relief of mild symptoms of intermittent asthma. The company was acquired by Amphastar Pharmaceuticals and now operates as a subsidiary focused on similar product lines. Their lead programs have reached commercial approval in the US market.
- Therapeutic areas
- Pulmonology
- Modalities
- Small moleculeInhaled respiratory drugs delivered by Metered Dose Inhalers (MDIs)Over-the-counter products
- Industry
- Biotech
Beyond the preview
Go deeper on Armstrong Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Armstrong Pharmaceuticals.